# Applied Biology, Inc. clinical trials: 25 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials with Applied Biology, Inc. as lead sponsor, 5 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Applied Biology, Inc.: 25 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/applied-biology-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 11, 2026 | NCT07402330 | Pharmacokinetic Study of DA-020 | Applied Biology, Inc. | Early phase 1 | Withdrawn | Chemotherapy Induced Alopecia, Chemotherapy Side Effects | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07402330) |
| February 9, 2026 | NCT07397325 | Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia | Applied Biology, Inc. | Phase 1/2 | Recruiting | Chemotherapy Induced Alopecia, Chemotherapy Side Effects | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397325) |
| September 10, 2025 | NCT07166354 | Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities) | Applied Biology, Inc. | Phase 1/2 | Not yet recruiting | Canities, Grey Hair | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07166354) |
| June 24, 2025 | NCT07033845 | Pharmacokinetic Study of Topical Phenylephrine | Applied Biology, Inc. | Early phase 1 | Withdrawn | Chemotherapy Induced Alopecia, Chemotherapy Side Effects | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07033845) |
| January 7, 2025 | NCT06762548 | Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia | Applied Biology, Inc. | Phase 3 | Not yet recruiting | Chemotherapy Induced Alopecia, Chemotherapy Side Effects | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06762548) |
| December 20, 2024 | NCT06745336 | Clinical Study of CS-001 as a Treatment for Canities (Grey Hair) | Applied Biology, Inc. | Phase 3 | Not yet recruiting | Canities, Grey Hair | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06745336) |
| October 18, 2024 | NCT06648850 | Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth | Applied Biology, Inc. | Phase 2/3 | Not yet recruiting | Telogen Effluvium, Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia, Male Pattern Baldness... | 1,120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06648850) |
| July 15, 2024 | NCT06501924 | Clinical Study of DA-002 and DA-005 as a Treatment for Hair Loss | Applied Biology, Inc. | Phase 3 | Withdrawn | Androgenetic Alopecia, Female Pattern Baldness, Male Pattern Baldness | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06501924) |
| July 3, 2024 | NCT06484881 | Clinical Study of Probiotic Treatment for Androgenetic Alopecia | Applied Biology, Inc. | Phase 3 | Withdrawn | Androgenetic Alopecia, Female Pattern Baldness | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06484881) |
| October 23, 2023 | NCT06095739 | Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 | Applied Biology, Inc. | Not applicable | Completed | Hair Diseases, Alopecia, Hair Loss | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06095739) |
| August 19, 2022 | NCT05507372 | Treatment for Post Acute COVID-19 Syndrome | Applied Biology, Inc. | Not applicable | Unknown | Tinnitus, Subjective | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05507372) |
| August 23, 2021 | NCT05016284 | Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis | Applied Biology, Inc. | Phase 3 | Withdrawn | Atopic Dermatitis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05016284) |
| August 2, 2021 | NCT04986176 | HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients | Applied Biology, Inc. | Phase 3 | Unknown | COVID-19 Respiratory Infection | 602 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04986176) |
| April 22, 2021 | NCT04853927 | Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit | Applied Biology, Inc. | Phase 3 | Withdrawn | Covid19, SARS (Severe Acute Respiratory Syndrome) | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04853927) |
| April 21, 2021 | NCT04853134 | Proxalutamide Treatment for COVID-19 Female Outpatients | Applied Biology, Inc. | Phase 3 | Withdrawn | Covid19, SARS-CoV Infection | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04853134) |
| January 28, 2021 | NCT04728802 | Proxalutamide Treatment for Hospitalized COVID-19 Patients | Applied Biology, Inc. | Phase 3 | Completed | Covid19, SARS (Severe Acute Respiratory Syndrome) | 645 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04728802) |
| June 24, 2020 | NCT04446429 | Anti-Androgen Treatment for COVID-19 | Applied Biology, Inc. | Not applicable | Completed | COVID-19, SARS-CoV2, Androgenetic Alopecia, Prostate Cancer, Benign Prostatic Hyperplasia, SARS (Severe Acute... | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04446429) |
| May 7, 2020 | NCT04379583 | HairDx Analytical Validation Study | Applied Biology, Inc. | Observational | Withdrawn | Hair Loss, Hair Loss/Baldness, Female Pattern Baldness, Androgenetic Alopecia | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04379583) |
| April 30, 2020 | NCT04368897 | In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity | Applied Biology, Inc. | Observational | Withdrawn | SARS-CoV 2, COVID, COVID-19, Androgenetic Alopecia, Androgen Receptor Abnormal, Androgen Deficiency | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04368897) |
| July 19, 2018 | NCT03592121 | Study to Investigate the Effect of AB-101 in Breast Cancer Survivors | Applied Biology, Inc. | Early phase 1 | Completed | Sexual Dysfunction, Sexual Arousal Disorder, Sexual Dysfunction, Physiological, Breast Cancer, Nipple Disorder... | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03592121) |
| August 1, 2014 | NCT02206802 | Minoxidil Response Testing in Females With Female Pattern Hair Loss | Applied Biology, Inc. | Observational | Completed | Alopecia, Female Pattern Hair Loss | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02206802) |
| July 23, 2014 | NCT02198261 | Minoxidil Response Testing in Males With Androgenetic Alopecia | Applied Biology, Inc. | Observational | Completed | Androgenetic Alopecia | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02198261) |
| November 25, 2013 | NCT01992185 | Photocil (Topical) for the Treatment of Vitiligo | Applied Biology, Inc. | Not applicable | Completed | Vitiligo | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01992185) |
| November 25, 2013 | NCT01992172 | Photocil (Topical) for the Treatment of Atopic Dermatitis | Applied Biology, Inc. | Not applicable | Completed | Atopic Dermatitis | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01992172) |
| August 5, 2013 | NCT01916629 | Photocil (Topical) for the Treatment of Psoriasis Vulgaris | Applied Biology, Inc. | Not applicable | Completed | Psoriasis | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01916629) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 3 |
| Phase 1/2 | 2 |
| Phase 2/3 | 1 |
| Phase 3 | 9 |
| Not applicable | 6 |
| Observational | 4 |

## By status

| Status | Trials |
| --- | --- |
| Withdrawn | 9 |
| Completed | 9 |
| Not yet recruiting | 4 |
| Unknown | 2 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Alopecia | 9 |
| COVID-19 | 5 |
| Severe Acute Respiratory Syndrome | 4 |
| Dermatitis, Atopic | 2 |
| Vitiligo | 1 |
| Tinnitus | 1 |
| Prostatic Neoplasms | 1 |
| Prostatic Hyperplasia | 1 |
| Psoriasis | 1 |
| Hair Diseases | 1 |
| Sexual Dysfunction, Physiological | 1 |
| Sexual Dysfunctions, Psychological | 1 |
| Breast Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Process servers in the United States](https://specstream.ai/data/businesses/process-servers/united-states)
- [Tenant and eviction law firms in the United States](https://specstream.ai/data/businesses/tenant-and-eviction-law-firms/united-states)
- [Art restoration companies in the United States](https://specstream.ai/data/businesses/art-restoration-companies/united-states)
- [Certification bodies in the United States](https://specstream.ai/data/businesses/certification-bodies/united-states)
- [Environmental abatement companies in the United States](https://specstream.ai/data/businesses/environmental-abatement-companies/united-states)
- [Immunodermatology practices in the United States](https://specstream.ai/data/businesses/immunodermatology-practices/united-states)
